Company: BIVIW
Filing Date: 2025-07-22
Form Type: S-1/A
Source: 0001520138-25-000216
Chunk: 64

Company: BIOVIE INC.
Filing Date: 2025-07-22
Form: S-1/A
Chunk 64
---
 by us in this offering, and the actual public offering price for these securities, will be determined following
a broad public marketing effort over several trading days, and final distribution of these securities will ultimately be determined by
the underwriters. Nasdaq has also published guidance that an offering of securities that are “deeply discounted” to the “minimum
price” (for example a discount of 50% or more) will typically preclude a determination that the offering qualifies as Public Offering
for purposes of the stockholder approval rule. We cannot assure you that Nasdaq will determine that this offering will be deemed a Public
Offering under the stockholder approval rule. If Nasdaq determines that this offering was not conducted in compliance with the stockholder
approval rule, Nasdaq may cite a deficiency and move to delist our securities from Nasdaq. Upon a delisting from Nasdaq, our stock would
likely be traded in the over-the-counter inter-dealer quotation system, more commonly known as the “OTC.” OTC transactions
involve risks in addition to those associated with transactions in securities traded on the securities exchanges, such as Nasdaq, or,
together, Exchange-listed stocks. Many OTC stocks trade less frequently and in smaller volumes than exchange-listed stocks. Accordingly,
our stock would be less liquid than it would be otherwise. Also, the prices of OTC stocks are often more volatile than Exchange-listed
stocks. Additionally, institutional investors are usually prohibited from investing in OTC stocks, and it might be more challenging to
raise capital when needed.

<div align='center'>29</div>

We do not intend to pay dividends
on our Common Stock, so any returns will be limited to the value of our Common Stock.

We currently anticipate that we will retain any
future earnings to finance the continued development, operation and expansion of our business. As a result, we do not anticipate declaring
or paying any cash dividends or other distributions in the foreseeable future. If we do not pay dividends, our Common Stock may be less
valuable because stockholders must rely on sales of their Common Stock after price appreciation, which may never occur, to realize any
gains on their investment.

You may experience future dilution
as a result of future equity offerings or if we issue shares subject to options, warrants, stock awards or other arrangements.

In order to raise additional capital, we may in
the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock